FDA.reportPublic FDA data

nelfinavir mesylate 625 MG Oral Tablet

RxCUI
403978
RxNorm name
nelfinavir mesylate 625 MG Oral Tablet
Display name
nelfinavir mesylate 625 MG Oral Tablet
Full name
nelfinavir mesylate 625 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIRACEPTNELFINAVIR MESYLATEAGOURONe72c2bc6-9462-4a2e-8e1d-b97592376cbd2025-12-11Warnings, Adverse reactionsExact identifier
rxcui: 403978

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e72c2bc6-9462-4a2e-8e1d-b97592376cbdnelfinavir mesylate 625 MG Oral Tablet [PSN] · nelfinavir 625 MG Oral Tablet [SCD]235These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT. VIRACEPT ® (nelfinavir mesylate) Tablets, for oral use VIRACEPT ® (nelfinavir mesylate) Oral Powder, for oral use Initial U.S. Approval: 199720251211
9b370904-d2cd-4585-bc48-a8110621c8bdnelfinavir mesylate 625 MG Oral Tablet [PSN] · nelfinavir 625 MG Oral Tablet [SCD]21VIRACEPT ® (nelfinavir mesylate) TABLETS and ORAL POWDER20100413